Monday, 28 September 2026Updated 5m ago

← Top stories

MOREPENLAB

Morepen Laboratories Limited · ₹120.38 +3.2% on 25 Sept · 1M +24.1% · 3M +120.2% · 1 stories in 60 days · 1 positive · 0 negative

Open the company tag: stories, tone, the tags it comes with →

Price and news

NSE daily close · markers = sessions where news first traded

Positive newsNegative newsNeutral

▲

Morepen Laboratories submits first ANDA to USFDA for Sitagliptin Tablets

Morepen Laboratories submitted its first ANDA to USFDA for Sitagliptin Tablets
The US filing advances Morepen’s pharma pipeline, though no approval or commercial timeline is reported

Morepen Laboratories USFDA Pharma and healthcare1 source · 2h